ToxStrategies scientists have developed a range of plausible toxicity values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) based on application of systematic review methods and quantitative integration… read more
ToxStrategies is excited to be participating in the Society for Risk Analysis (SRA)’s 2020 Annual Meeting, which will be held virtually December 13-17th. We have two virtual poster presentations this year. Camarie… read more
EpidStrategies is excited to be participating in the American Society of Hematology (ASH) Annual Meeting, which will be held virtually on December 5-8, 2020. Xiaohui Jiang will… read more
ToxStrategies scientists Dr. Mark Harris, Dr. Deborah Proctor, and Dr. Chad Thompson are among the authors of a recently published study that proposes a cytotoxicity-mediated adverse outcome… read more
ToxStrategies is pleased to announce that Dr. Kristina Ulrich has joined our Biopharmaceuticals and Pharmaceuticals practice. Dr. Ulrich is a European Registered Toxicologist (ERT) and a… read more
Dr. Naushin Hooda, an EpidStrategies Doctor of Pharmacy based in Toronto, will participate in a virtual panel discussion as part of the Canadian… read more
ToxStrategies scientist, Dr. Laurie Haws was recently elected to the Board of Directors for The Toxicology Forum. The Toxicology Forum is a leading… read more
ToxStrategies authors, Dr. Daniele Wikoff and Dr. Allison Franzen, and colleagues have published a framework for use of systematic mapping and systematic reviews in… read more
